About Neopharma
Neopharma is a company based in Abu Dhabi (United Arab Emirates) founded in 2003. It operates as a B2B. The company has 43 employees as of March 31, 2023. Neopharma has completed 1 acquisition, including KYOWA CritiCare. Neopharma offers products and services including API Manufacturing, Finished Products, and Therapies. Neopharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
- Headquarter Abu Dhabi, United Arab Emirates
- Employees 43 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neo Pharma Private Limited
- Date of Incorporation 09 Mar, 1950
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$8.07 M (USD)-74.68as on Mar 31, 2023
-
Net Profit
$2.23 M (USD)-64.71as on Mar 31, 2023
-
EBITDA
$233.97 K (USD)-96.34as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
43
as on Mar 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neopharma
Neopharma offers a comprehensive portfolio of products and services, including API Manufacturing, Finished Products, and Therapies.
Production of active pharmaceutical ingredients for global use.
Creation of branded and generic pharmaceutical formulations worldwide.
Development and supply of therapeutic solutions for various needs.
People of Neopharma
Unlock access to complete
Funding Insights of Neopharma
Detailed funding history for Neopharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neopharma
Neopharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include KYOWA CritiCare.
Investment portfolio details for Neopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Critical care drugs and injections are manufactured by KYOWA CritiCare.
|
Locked | Locked | 1947 | Locked |
Complete acquisition details for Neopharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Neopharma
Detailed financials for Neopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neopharma Comparisons
Peer comparison for Neopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neopharma
Neopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of Neopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neopharma
Complete news archive for Neopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neopharma
Neopharma was founded in 2003.
Neopharma is headquartered in Abu Dhabi, United Arab Emirates. It is registered at Abu Dhabi, Abu Dhabi, United Arab Emirates.
As of Mar 31, 2023, the latest employee count at Neopharma is 43.
Annual revenue of Neopharma is $8.07M as on Mar 31, 2023.
Neopharma, founded in 2003, is a global pharmaceutical company with manufacturing facilities across three continents and offices in over 50 countries. It produces branded and generic formulations, as well as active pharmaceutical ingredients, focusing on high-quality, affordable medications through innovation and distribution networks. The company emphasizes commitment, excellence, and integrity in healthcare delivery, serving markets via partnerships and global supply chains from locations like Abu Dhabi.
Neopharma's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Neopharma offers API Manufacturing, Finished Products, and Therapies.
Neopharma has made 1 acquisition, including KYOWA CritiCare.